— Know what they know.
Not Investment Advice

ECS.AX ASX

ECS Botanics Holdings Ltd
1W: +10.0% 1M: -8.3% 3M: +10.0% YTD: +10.0% 1Y: -21.4% 3Y: -77.1% 5Y: -85.5%
A$0.01 ($0.00)
+0.00 (+0.00%)
 
Weekly Expected Move ±18.4%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · A$8.8M mcap · 1.58B float · 0.056% daily turnover

Income Trends

Revenue
$21M +8.5% ▲
5Y CAGR: +75.9%
Gross Profit
$80K -98.6% ▼
Operating Income
-$7M +23.0% ▲
Net Income
-$2M +66.8% ▲
EPS (Diluted)
$-0.00 +70.5% ▲
EBITDA
-$6M -149.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$5M$15M$20M$19M$21M
YoY Growth+324.9%+190.4%+30.2%-3.3%+8.5%
Cost of Revenue$3M$16M$18M$14M$21M
Gross Profit$2M$5M$9M$6M$80K
Gross Margin46.8%34.5%45.6%29.1%0.4%
R&D Expenses$120K$22K$10K$123K$83K
SG&A Expenses$2M$5M$6M$2M$4M
Operating Expenses$3M$5M$3M$9M$7M
Operating Income-$2M-$3M-$668K-$9M-$7M
Operating Margin-33.3%-19.6%-3.3%-44.6%-31.6%
Interest Expense$0$41K$62K$314K$515K
Income Before Tax$174K$491K$2M-$7M-$1M
Tax Expense$8K$0-$70K$1M$875K
Net Income-$1M-$82K$2M-$6M-$2M
Net Margin-21.0%-0.5%9.6%-29.6%-9.1%
EPS (Diluted)$-0.00$0.00$0.00$-0.00$-0.00
EBITDA-$59K$2M$3M-$2M-$6M
Shares Outstanding1.03B1.11B1.22B1.35B1.46B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms